Maturity‐Onset Diabetes of the Young (MODY) With HNF1B p.Glu105Lys Mutation Achieving Significant Insulin Reduction on Tirzepatide: A Case Report

Documenti analoghi

• Heterogeneous Phenotypic Evolution in ANO3‐Related Dystonia Due to the Recurrent p.Glu510Lys Variant
  di: Elisabetta Indelicato, et al.
  Pubblicazione: (2024)
• Reply to: “Heterogeneous Phenotypic Evolution in ANO3‐Related Dystonia Due to the Recurrent p.Glu510Lys Variant”
  di: Luigi M. Romito, et al.
  Pubblicazione: (2024)
• Clinical effects of SGLT2 inhibitors in seven persons with HNF1A‐MODY (MODY3)
  di: Henrik Maagensen, et al.
  Pubblicazione: (2024)
• Sulphonylurea efficacy and end‐organ outcomes in the management of HNF4A ‐ MODY
  di: M. T. Crowley, et al.
  Pubblicazione: (2025)
• HNF1β Gene Mutation Leading to a MODY5 With Renal Dysplasia: A Case Report
  di: Xingfa Han, et al.
  Pubblicazione: (2025)